LINDA HAMMONS, FNP
Continuing Education/Staff Development Registered Nurse in SAN BERNARDINO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
LINDA HAMMONS, FNP filed 264 Medicare Part D claims in 2023 as a Continuing Education/Staff Development Registered Nurse in SAN BERNARDINO, California, prescribing 52% generic.
- 264
- Part D claims, 2023
- 52%
- generic prescribing
- $24.86
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
LINDA HAMMONS, FNP's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
264 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about LINDA HAMMONS, FNP?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Continuing Education/Staff Development Registered Nurse compares to other specialties among California providers
Continuing Education/Staff Development Registered Nurse share within California
Continuing Education/Staff Development Registered Nurse is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Continuing Education/Staff Development Registered Nurse (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Continuing Education/Staff Development Registered Nurse ABMS/AOA estimate
Est. board-certified rate (Continuing Education/Staff Development Registered Nurse) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Continuing Education/Staff Development Registered Nurse US NPIs
Specialty board-certified rate — Continuing Education/Staff Development Registered Nurse estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
LINDA HAMMONS, FNP appears in the CMS NPPES registry as a Continuing Education/Staff Development Registered Nurse provider holding FNP credentials at 2101 N WATERMAN AVE, SAN BERNARDINO, CA, 92404, with a listed phone of (909) 883-8711. NPI 1497057061 was issued on 12/02/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAMMONS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 264 prescription claims written by this provider, covering 23 Medicare beneficiaries and totaling roughly $56K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Continuing Education/Staff Development Registered Nurse is a narrow specialty nationwide, with 422 enrolled providers across 51 states and an average of 992 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1497057061 |
|---|---|
| Specialty | Continuing Education/Staff Development Registered Nurse |
| Credentials | FNP |
| Gender | Female |
| NPI Issued | 12/02/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm LINDA HAMMONS, FNP's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LINDA HAMMONS, FNP. Source: openpaymentsdata.cms.gov.
Total received
$25
Largest payer
Inari Medical, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to LINDA HAMMONS, FNP. To verify LINDA HAMMONS, FNP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
48% brand-name claims vs 52% generic, on 264 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 295
- Total Day Supply
- 6,393
- Brand vs Generic
- 48% brand / 52% generic
- Brand Drug Cost
- $51K
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 61.0 years
- Avg HCC Risk Score
- 9.45
- Age Distribution
- <65: 12, 65-74: N/A, 75-84: N/A, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What LINDA HAMMONS, FNP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prosol
Prosol
74 claims
- Clinolipid 28
Clinolipid
28 claims
- Amlodipine Besylate 21
Amlodipine Besylate
21 claims
- Trazodone Hcl 12
Trazodone Hcl
12 claims
| Drug | Claims |
|---|---|
| Prosol Parenteral Amino Acid 20% No.1 | 74 |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 28 |
| Amlodipine Besylate | 21 |
| Trazodone Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Continuing Education/Staff Development Registered Nurse Overview
How LINDA HAMMONS, FNP fits within the Continuing Education/Staff Development Registered Nurse landscape nationally.
LINDA HAMMONS, FNP's 264 claims are below the specialty average of 992.
Nearby Continuing Education/Staff Development Registered Nurse Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HAMMONS.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is LINDA HAMMONS, FNP's specialty? ▼
How much does LINDA HAMMONS, FNP prescribe under Medicare Part D? ▼
Where is LINDA HAMMONS, FNP located? ▼
What is LINDA HAMMONS, FNP's NPI number? ▼
Does LINDA HAMMONS, FNP prescribe more brand-name or generic drugs? ▼
How many Continuing Education/Staff Development Registered Nurse providers are there in the US? ▼
What drugs does LINDA HAMMONS, FNP prescribe most often? ▼
Does LINDA HAMMONS, FNP accept Medicare? ▼
How can I verify LINDA HAMMONS, FNP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology